Abstract
Dry eye in the elderly population is a condition with a multitude of contributing factors and a wide spectrum of severity. The complex tear film is made up of layers of oil, aqueous and mucin, produced by the meibomian glands, main and accessory lacrimal glands, and by the goblet cells, respectively. Alteration in the normal function of any of these structures by disease, trauma or the environment can cause dysfunction of the tear film and result in the symptoms of dry eye (such as burning, grittiness and blurred vision).
Normal lid anatomy and closure is critical to prevent evaporation of the normal tear film. The mainstay of current therapy is augmentation of the tear film with artificial tears and ointment. More severe cases of dry eye may require occlusion of the tear drainage system with plugs or electrocautery scarring. Good lid hygiene is also important for tear film health.
A new paradigm of dry eye as a subclinical inflammatory disease has recently been suggested, and preliminary results from treatment with topical cyclosporin formulations are encouraging. The next few years promise exciting advances and relief for patients suffering from this chronic condition.
Similar content being viewed by others
References
Schein OD, Munoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997; 124: 728–9
Terry MA. Corneal abrasions and corneal ulcerations. In: Cioffi GA, editor. The Devers manual: ophthalmology for the health care professional. Baltimore: Williams & Wilkins, 1997: 131–7
Holly FJ, Lemp MA. Tear physiology and dry eye. Surv Ophthalmol 1977; 22: 69–87
Sires BS, Lemke BN, Kincaid MC. Orbital and ocular anatomy. In: Wright KW, editor. Textbook of ophthalmology. Baltimore: Williams & Wilkins, 1997: 3–54
Cioffi GA. Dry eye syndrome (keratoconjunctivitis sicca). In: Cioffi GA, editor. The Devers manual: ophthalmology for the health care professional. Baltimore: Williams & Wilkins, 1997: 72–8
Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: the interaction between the ocular suture and ocular glands. Cornea 1998; 17: 584–9
Seal DV. The effect of aging and disease on tear constituents. Trans Ophthalmol Soc U K 1985; 104 (Pt 4): 355–62
Terry MA. Ocular trauma. In: Cioffi GA, editor. The Devers manual: ophthalmology for the health care professional. Baltimore: Williams and Wilkins, 1997: 79–91
Wilson MW, Dailey RA. Eyelid malpositions. In: Cioffi GA, editor. The Devers manual: ophthalmology for the health care professional. Baltimore: Williams and Wilkins, 1997: 27–35
Murillo-Lopez F, Pflugfelder Sc. Dry eye. In: Krachmer JH, Mannis MJ, Holland, editors. Cornea. St Louis (MO): Mosby Year Book, 1997: 663–86
Roat M. Ocular cicatricial pemphigoid: a scientific and practical approach to diagnosis and treatment. Semin Ophthalmol 1991; 6: 142–55
Terry MA. Blepharitis. In: Cioffi GA, editor. The Devers manual: ophthalmology for the health care professional. Baltimore: Williams and Wilkins, 1997: 51–60
Clinch TE, Benedetto DA, Felberg NT, et al. Schirmer’s Test: a closer look. Arch Opthalmol 1983; 101: 1383–6
Terry MA. Refractive errors and their correction. In: Cioffi GA, editor. The Devers manual: ophthalmology for the health care professional. Baltimore: Williams and Wilkins, 1997: 138–45
Terry MA. Ocular herpetic infections. In: Cioffi GA, editor. The Devers manual: ophthalmology for the health care professional. Baltimore: Williams and Wilkins, 1997: 181–8
Tsubota K, Monden Y, Yagi Y, et al. New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery. Br J Ophthalmol 1999; 83: 767–70
Gao J, Schwalb TA, Addeo JV, et al. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical cyclosporin A therapy. Cornea 1998; 17: 654–63
Stern, ME, Smith, JA. The pathophysiology of dry eye and the role of cyclosporine as a therapeutic agent. Ther Updates Ophthalmol 1998; 2: 6–8
Marsh P, Pflugfelder SC. Topical non-preserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 1999; 106: 811–6
Stevenson D, Tauber J, Reis BL. Efficacy and safety of cyclosporine A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporine APhase 2 Study Group. Ophthalmology 2000; 107: 967–74
Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000; 107: 631–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Terry, M.A. Dry Eye in the Elderly. Drugs & Aging 18, 101–107 (2001). https://doi.org/10.2165/00002512-200118020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200118020-00003